Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol
Titel:
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol
Auteur:
Sargos, Paul Bellera, Carine Bentahila, Rita Guerni, Marie Benziane-Ouaritini, Nicolas Teyssonneau, Diego Vuong, Nam-Son Ploussard, Guillaume Roupret, Morgan Roubaud, Guilhem